The Barts Cancer Institute at Queen Mary University of London is offering a 4-year fully funded PhD position in Cancer Immunology and Lymphoma Research, supervised by Professor Jessica Okosun. The project focuses on investigating the dynamics and evolution of the lymphoma immunome across disease progression and therapeutic intervention, using patient-derived samples, single-cell profiling, immune repertoire analysis, and computational bioinformatics approaches. The research aims to identify immune biomarkers or signatures associated with disease progression and therapeutic response, providing insights to guide translational, therapeutic, and immunotherapeutic strategies in lymphoma.

The successful candidate will join a collaborative, interdisciplinary lab at the intersection of cancer biology, genomics, immunology, and precision medicine. The project will involve high-resolution profiling techniques, including single-cell analysis and spectral flow cytometry, as well as bioinformatic analysis of large datasets. The student will gain experience in functional immunological assays, research governance, and clinical translation, working with clinical samples and tissue banks.

Applicants should have or expect to obtain a first or upper second class honours degree in a relevant biological subject or a medical degree. Non-native English speakers require a minimum IELTS score of 6.5 (with 6.0 in writing) or equivalent. The studentship provides a tax-free annual stipend of £23,000, tuition fees at the Home rate, and project consumables. Overseas applicants are welcome but must cover the difference in tuition fees.

The application deadline is March 6, 2026, with the project starting in September 2026. To apply, complete the online application form and submit all required documents. For further information, contact Professor Jessica Okosun or the BCI postgraduate research office. This opportunity is ideal for students interested in cancer immunology, lymphoma biology, single-cell genomics, and translational research.